|
End-of-day quote
Nasdaq
2026-09-01
|
5-day change | 1st Jan Change | ||
| 5.240 USD | +0.96% |
|
+3.76% | +2.14% |
| 08-31 | Alvotech Shares Rise After FDA Accepts Biologics License Application for AVT80 | MT |
| 08-31 | Alvotech's Application for Proposed Entyvio Biosimilar Accepted for US FDA Review | MT |
Transcripts
Search
No results match your criteria
- Stock Market
- Stocks
- ALVO Stock
- News Alvotech
- Transcripts
Select your edition
All financial news and data tailored to specific country editions
















